A record of literary properties sold at auction in the United States.

Building in existing fabric requires more than practical solutions and stylistic skills. The adaptive reuse of buildings, where changes in the structure go along with new programs and functions, poses the fundamental question of how the past should be included in the design for the future. On the background of long years of teaching and publishing, and using vivid imagery from Frankenstein to Rem Koolhaas and beyond, the author provides a comprehensive introduction to architectural design for adaptive reuse projects. History and theory, building typology, questions of materials and construction, aspects of preservation, urban as well as interior design are dealt with in ways that allow to approach adaptive reuse as a design practice field of its own right.

The World Malaria Report 2015assesses global malaria disease trends and changes in the coverage and financing of malaria control programs between 2000 and 2015. It also summarizes progress towards international targets, and provides regional and country profiles that summarize trends in each WHO region and each country with malaria. The report is produced with the help of WHO regional and country offices, ministries of health in endemic countries, and a broad range of other partners. The data presented are assembled from the 96 countries and territories with ongoing malaria transmission, and a further five countries that have recently eliminated malaria. Most data are those reported for 2014 and 2015, although in some cases projections have been made into 2015, to assess progress towards targets for 2015.

These guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and the care of people living with HIV. They are structured along the continuum of HIV testing, prevention, treatment and care. This edition updates the 2013 consolidated guidelines on the use of antiretroviral drugs following an extensive review of evidence and consultations in mid-2015, shared at the end of 2015, and now published in full in 2016. It is being published in a changing global context for HIV and for health more broadly.

The outsourcing of clinical trials to Latin America by the transnational innovative pharmaceutical industry began about twenty years ago. Using archival information and field work in Argentina, Brazil, Costa Rica, Mexico and Peru, the authors discuss the regulatory contexts and the ethical dimensions of human experimentation in the region. More than 80% of all clinical trials in the region take place in these countries, and the European Medicines Agency has defined them as priority countries in Latin America. The authors raise questions about the quality of data obtained from the trials and the violation of human rights during their implementation. Their findings are presented in this volume, the first in-depth analysis of clinical trials in the region. ​

R. C. Lewontin is a prominent scientist -- a geneticist who teaches at Harvard -- yet he believes that we have placed science on a pedestal, treating it as an objective body of knowledge that transcends all other ways of knowing and all other endeavours. Lewontin writes in this collection of essays, which began their life as CBC Radio's Massey Lectures Series for 1990: "Scientists do not begin life as scientists, after all, but as social beings immersed in a family, a state, a productive structure, and they view nature through a lens that has been molded by their social experience... . Science, like the Church before it, is a supremely social institution, reflecting and reinforcing the dominant values and vices of society at each historical epoch." In Biology as Ideology Lewontin examines the false paths down which modern scientific ideology has led us. By admitting science's limitations, he helps us rediscover the richness of nature -- and appreciate the real value of science.